Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on July 31, 2003

Arteriosclerosis, Thrombosis, and Vascular Biology. 2003
Published online before print July 31, 2003, doi: 10.1161/01.ATV.0000089328.23279.3F
A more recent version of this article appeared on September 1, 2003
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/9/1653    most recent
01.ATV.0000089328.23279.3Fv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kujiraoka, T.
Right arrow Articles by Miller, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kujiraoka, T.
Right arrow Articles by Miller, N. E.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LECITHIN
Related Collections
Right arrow Lipids
Right arrow Lipid and lipoprotein metabolism

Submitted on January 27, 2003
Accepted on July 10, 2003

Effects of Intravenous Apolipoprotein A-I/Phosphatidylcholine Discs on LCAT, PLTP, and CETP in Plasma and Peripheral Lymph in Humans

Takeshi Kujiraoka ; M. Nazeem Nanjee ; Tomoichiro Oka ; Mayumi Ito ; Makoto Nagano ; C. Justin Cooke ; Sadao Takahashi ; Waldemar L. Olszewski ; Jinny S. Wong ; Irina P. Stepanova ; Robert L. Hamilton ; Tohru Egashira ; Hiroaki Hattori *; and Norman E. Miller

From the Department of Advanced Medical Technology and Development (T.K., T.O., M.I., M.N., T.E., H.H.), BML Inc, Saitama, Japan; Department of Cardiovascular Biochemistry (M.N.N., C.J.C., I.P.S., N.E.M.), St Bartholomew's and the Royal London School of Medicine and Dentistry, London, UK; Third Department of Internal Medicine (S.T.), Fukui Medical University, Fukui, Japan; Medical Research Center (W.L.O.), Polish Academy of Sciences, Warsaw, Poland; Cardiovascular Research Institute and Department of Anatomy (J.S.W., R.L.H.), University of California, San Francisco, Calif.

* To whom correspondence should be addressed. E-mail: hhiro{at}bml.co.jp.

Objective--We have previously shown that intravenous apolipoprotein A-I/phosphatidylcholine (apoA-I/PC) discs increase plasma pre-{beta} HDL concentration and stimulate reverse cholesterol transport (RCT) in humans. We have now investigated the associated changes in the following 3 HDL components that play key roles in RCT: lecithin:cholesterol acyltransferase (LCAT), cholesteryl ester transfer protein (CETP), and phospholipid transfer protein (PLTP).

Methods and Results--apoA-I/PC discs (40 mg/kg over 4 hours) were infused into 8 healthy men. Samples of blood and prenodal peripheral lymph were collected for 24 to 48 hours. At 12 hours, plasma LCAT concentration had increased by 0.40±0.90 mg/L (+7.8%; mean±SD; P<0.05), plasma cholesterol esterification rate by 29.0±9.0 nmol/mL per h (+69.5%; P<0.01), plasma CETP concentration by 0.5±0.2 mg/L (+29.7%; P<0.01), and plasma PLTP activity by 1.45±0.67 µmol/mL per h (+23.9%; P<0.01). In contrast, plasma PLTP concentration had decreased by 4.4±2.7 mg/L (-44.8%; P<0.01). The changes in PLTP were accompanied by alterations in the relative proportions of large lipoproteins containing inactive PLTP and small particles containing PLTP of high specific activity. No changes were detected in peripheral lymph.

Conclusions--Nascent HDL secretion may induce changes in PLTP, LCAT, and CETP that promote RCT by catalyzing pre-{beta} HDL production, cholesterol esterification in HDLs, and cholesteryl ester transfer from HDLs to other lipoproteins.


Key words: apolipoprotein A-I • phospholipid transfer protein • lecithin • cholesterol acyltransferase • cholesteryl ester transfer protein




This article has been cited by other articles:


Home page
J. Lipid Res.Home page
M. C. Cheung and J. J. Albers
Active plasma phospholipid transfer protein is associated with apoA-I- but not apoE-containing lipoproteins
J. Lipid Res., June 1, 2006; 47(6): 1315 - 1321.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Olchawa, B. A. Kingwell, A. Hoang, L. Schneider, O. Miyazaki, P. Nestel, and D. Sviridov
Physical Fitness and Reverse Cholesterol Transport
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 1087 - 1091.
[Abstract] [Full Text] [PDF]